Clinical Commissioning Policies
This page lists the Clinical Commissioning Policies – known locally as Lavender Statements – that have been adopted by OCCG’s Board. NHS organisations caring for Oxfordshire patients must take account of these statements when considering treatment or referral to other specialists.
267b Sequential Use of Biologics in Opthalmology
268b Sequential Use of Biologics in Psoriatic Arthritis
269c Subacromial Decompression of the Shoulder
271d Revision of Hip And Knee Replacement
272a Management of Low Back Pain and Sciatica
273a Facet Joint Injection And Medial Branch Block For Chronic Neck Pain
274a Melatonin Treatment in Children
275a Open MRI
276a Autologous Blood Injections and Platelet Rich Plasma Injections
277 Oral Nutritional Supplements
278b Management of Female Pelvic Organ Prolapse
279a Functional Electrical Stimulation
280a TVPC 70 Ectropion and entropion
282a TVPC67 NHSE specialised commissioning
283a Management of Haemorrhoids